Anti-IL-17F 抗体 [EPR17830-169] (ab187059)
![Flow Cytometry (Intracellular) - Anti-IL-17F antibody [EPR17830-169] (ab187059)](https://www.abcam.co.jp/ps/products/187/ab187059/Images/ab187059-308549-anti-il-17f-antibody-epr17830-169-flow-cytometry.jpg "Flow Cytometry (Intracellular) - Anti-IL-17F antibody [EPR17830-169] (ab187059)")
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR17830-169] to IL-17F
- Suitable for: Flow Cyt (Intra), IP, WB
- Reacts with: Mouse
Related conjugates and formulations
製品の概要
-
製品名
Anti-IL-17F antibody [EPR17830-169]
IL-17F 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR17830-169] to IL-17F -
由来種
Rabbit -
アプリケーション
適用あり: Flow Cyt (Intra), IP, WBmore details -
種交差性
交差種: Mouse -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ･コントロール
- WB: Mouse IL17F recombinant protein (aa29-161) ; EL4 cell lysate (treated with PMA, Ionomycin calcuim salt and Brefeldin A). Flow Cyt (intra): EL4 cells treated with PMA, Ionomycin calcuim salt and Brefeldin A. IP: EL4 cells treated with PMA, Ionomycin calcuim salt and Brefeldin A.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading... -
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR17830-169 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Isotype control
-
Related Products
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab187059の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
| アプリケーション | Abreviews | 特記事項 |
|---|---|---|
| Flow Cyt (Intra) |
1/60.
|
|
| IP |
1/30.
|
|
| WB |
1/1000. Predicted molecular weight: 18 kDa.
|
| 特記事項 |
|---|
|
Flow Cyt (Intra)
1/60. |
|
IP
1/30. |
|
WB
1/1000. Predicted molecular weight: 18 kDa. |
ターゲット情報
-
機能
Ligand for IL17RA and IL17RC (PubMed:17911633). The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC (PubMed:18684971). Involved in stimulating the production of other cytokines such as IL6, IL8 and CSF2, and in regulation of cartilage matrix turnover (PubMed:11591732, PubMed:11591768, PubMed:11574464). Also involved in stimulating the proliferation of peripheral blood mononuclear cells and T-cells and in inhibition of angiogenesis (PubMed:11591732). Plays a role in the induction of neutrophilia in the lungs and in the exacerbation of antigen-induced pulmonary allergic inflammation. -
組織特異性
Expressed in activated, but not resting, CD4+ T-cells and activated monocytes. -
関連疾患
Candidiasis, familial, 6 -
配列類似性
Belongs to the IL-17 family. -
細胞内局在
Secreted. - Information by UniProt
-
参照データベース
- Entrez Gene: 257630 Mouse
- SwissProt: Q7TNI7 Mouse
- Unigene: 222807 Mouse
-
別名
- CANDF6 antibody
- Cytokine ML 1 antibody
- Cytokine ML-1 antibody
see all
画像
-
Flow Cytometry (Intracellular) - Anti-IL-17F antibody [EPR17830-169] (ab187059)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed 90% methanol-fixed EL4 (mouse lymphoma T lymphocyte) treated with 50ng/ml Phorbol-12-myristate-13-acetate (PMA) and 500ng/ml Ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours (Right) / Untreated control (Left) labeling IL17F with ab187059 at 1/60 dilution.
Secondary antibody used Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at a 1/2000 dilution.
-
![Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059)](https://www.abcam.co.jp/ps/products/187/ab187059/Images/ab187059-308546-anti-il-17f-antibody-epr17830-169-western-blot.jpg)
Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059)All lanes : Anti-IL-17F antibody [EPR17830-169] (ab187059) at 1/5000 dilution
Lane 1 : Mouse IL17A recombinant protein (aa26-158) 10 ng
Lane 2 : Mouse IL17F recombinant protein (aa29-161) 10 ng
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 18 kDa
Observed band size: 18 kDa
Exposure time: 26 secondsBlocking/Dilution buffer: 5% NFDM/TBST
-
![Immunoprecipitation - Anti-IL-17F antibody [EPR17830-169] (ab187059)](https://www.abcam.co.jp/ps/products/187/ab187059/Images/ab187059-308548-anti-il-17f-antibody-epr17830-169-immunoprecipitation.jpg)
Immunoprecipitation - Anti-IL-17F antibody [EPR17830-169] (ab187059)IL17F was immunoprecipitated from 0.35 mg of EL4 (mouse lymphoma T lymphocyte) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate with ab187059 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab187059 at 1/1,000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/5,000 dilution.
Lane 1: EL4 (mouse lymphoma T lymphocyte) treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate 10 μg (Input).
Lane 2: EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab187059 in EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added for the last 20 hours whole cell lysate.Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: 10 seconds
-
![Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059)](https://www.abcam.co.jp/ps/products/187/ab187059/Images/ab187059-308547-anti-il-17f-antibody-epr17830-169-western-blot.jpg)
Western blot - Anti-IL-17F antibody [EPR17830-169] (ab187059)All lanes : Anti-IL-17F antibody [EPR17830-169] (ab187059) at 1/1000 dilution
Lane 1 : Untreated EL4 (mouse lymphoma T lymphocyte), whole cell lysate
Lane 2 : EL4 treated with 50 ng/ml phorbol-12-myristate-13-acetate (PMA) and 500 ng/ml ionomycin calcium salt for 24 hours, and 500 ng/ml Brefeldin A (BFA) was added to the treated cells last 20 hours, whole cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 18 kDa
Observed band size: 16-18 kDa why is the actual band size different from the predicted?
Exposure time: 48 secondsBlocking/Diluting buffer: 5% NFDM/TBST
The molecular mass observed is consistent with the literature (PMID 2212322).
Expression of IL-17F in EL4 cells is increased by PMA and Ionomycin treatment (PMID 28382171).
-
![Anti-IL-17F antibody [EPR17830-169] (ab187059)](https://www.abcam.co.jp/ps/products/187/ab187059/Images/ab187059-5-benefits-of-recombinant-antibodies.png)
Anti-IL-17F antibody [EPR17830-169] (ab187059)
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (1)
ab187059 は 1 報の論文で使用されています。
- Bu J et al. Activation of the IL-17 signalling pathway by the CXCL17-GPR35 axis affects drug resistance and colorectal cancer tumorigenesis. Am J Cancer Res 13:2172-2187 (2023). PubMed: 37293165